BRAF-Mutated Acute Myeloid Leukemia (AML) Represents a Distinct Prognostically Poor Subgroup Enriched in Myelodysplasia-Related AML (Alliance)
   Google Scholar   
Citation:
Blood vol 41 (Supplement 1) 1575
Meeting Instance:
ASH 2023
Year:
2023
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
   
Pharmas:
 
Grants:
Support: U10CA180821, U10CA180882, U24CA196171;  
Corr. Author:
 
Authors:
                                                           
Networks:
CA043, CT063, LAPS-AL002, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-OH007, MD015, NC002, NORTHWELL, OH070   
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-20202, CALGB-8461, CALGB-9665
Phases:
N/A
Keywords: